Skip to main content

Table 1 Access to care and HIV, HBV and HCV status at prison entry and during prison stay.

From: Harm reduction and equity of access to care for French prisoners: a review

 

Mouquet

Mouquet

Remy

Remy

Drassif

 

1997 (%)

2003 (%)

2000 (%)

2003 (%)

2005 (%)

 

135 prisons Incoming inmates*

134 prisons Incoming inmates*

85 prisons 27 245 inmates**

88 prisons 31215 inmates**

8 prisons Incoming inmates***

HCV positive test

4.4a

4.2a

6.3b

6.9b

5.9 b

% of inmates screened

20

27

ND

ND

38

HBV positive test

2.3a

0.8a

  

3.4 b

% of inmates screened

25

20

  

37

HIV positive test

1.6a

1.1a

  

0.6 b

% of inmates screened

46

40

  

41

HAART at prison entry

0.8

0.5

  

1.4

HCV treatment (total number/1 year)

  

164

297

171

  1. *study period : from 2 weeks to 3 months depending of the size of the prison
  2. ** cross-sectional study
  3. ***study period : 2005
  4. aself-reported serostatus among those who reported to have had already been screened
  5. b positive test